Thrombosis angiogenesis

The book is comprised of five sections with part I covering systemic and endoluminal therapy with an incisive overview of hemostasis and thrombosis part II covers local therapy with several chapters devoted to drug-eluting stents and restenosis therapies part III covers cell therapy and therapeutic angiogenesis and includes chapters on cell transplantation and clinical trials in cellular therapy part IV covers adjunctive pharmacotherapy with chapters devoted to various patient populations including those with heart failure, diabetes, atrial fibrillation, peripheral artery disease,... 

MPs (also called microvesicles) are present in the blood of healthy individuals and are increased in various diseases including CVD. They are small membrane vesicles derived from activated and apoptotic cells. Importantly, MPs have been proposed to play roles in thrombosis, inflammation, and angiogenesis (103). MPs are also released in the circulation (104), and ever since their potent procoagulatory properties were first recognized in the field of homeostasis (105), the interest in their potential pathophysiological importance has increased (106). MP metabolome may be a useful and reliable source of biologically relevant disease biomarkers. 

There has also been considerable interest in the use of statins in other clinical indications, including cancer [75], neurological disorders [76], osteoporosis [77], atrial fibrillation [78], asthma [79], angiogenesis [80], immunomodulatory effects [81], coagulation and thrombosis [82,83]. Whether these effects can all be attributed to the cholesterol-lowering activity or are a consequence of depletion of other isoprenoid species remains to be determined. 

Katare, R., Riu, E., Rowlinson, J., Lewis, A., Holden, R., Meloni, M., Reni, C., Wallrapp, C., Emanueh, C., Madeddu, P. Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of vegf-a. Arteriosclerosis, Thrombosis And Vascular Biology 33, 1872-1880(2013)... 

---